European biotech raises $2.3B in first half of 2017

European biotech raises $2.3B in first half of 2017


European biotechnology firms engaged in drug discovery and development raised a total of $2.302 billion during the first half of the year, putting the sector on course for a creditable performance for 2017 as a whole. The running total for the first half of the year is 36 percent up on the equivalent figure of $1.69 billion for 2016 but behind that of 2015.



from Biotech News